Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,591 | 227 | 92.3% |
| Education | $382.98 | 4 | 7.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $1,246 | 57 | $0 (2024) |
| Lilly USA, LLC | $549.26 | 32 | $0 (2024) |
| ABBVIE INC. | $330.60 | 21 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $320.67 | 7 | $0 (2024) |
| Galderma Laboratories, L.P. | $297.51 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $288.11 | 13 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $260.07 | 14 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $248.67 | 8 | $0 (2024) |
| PFIZER INC. | $193.23 | 14 | $0 (2024) |
| Incyte Corporation | $175.90 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,284 | 72 | Lilly USA, LLC ($216.55) |
| 2023 | $1,390 | 70 | Janssen Biotech, Inc. ($325.44) |
| 2022 | $601.52 | 30 | Janssen Biotech, Inc. ($264.79) |
| 2021 | $694.40 | 25 | Janssen Biotech, Inc. ($243.31) |
| 2020 | $95.61 | 5 | Janssen Biotech, Inc. ($37.65) |
| 2019 | $374.37 | 9 | Janssen Biotech, Inc. ($117.34) |
| 2018 | $88.60 | 5 | Novartis Pharmaceuticals Corporation ($20.94) |
| 2017 | $445.42 | 15 | Galderma Laboratories, L.P. ($131.36) |
All Payment Transactions
231 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: DERMATOLOGY | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Immunology | ||||||
| 11/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/06/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: DERMATOLOGY | ||||||
| 11/06/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.72 | General |
| Category: Immunology | ||||||
| 10/30/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: DERMATOLOGY | ||||||
| 10/22/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Immunology | ||||||
| 10/11/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $13.35 | General |
| Category: Dermatology | ||||||
| 10/09/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $10.99 | General |
| 10/02/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: DERMATOLOGY | ||||||
| 09/30/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply), Odomzo | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Dermatology | ||||||
| 09/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: Immunology | ||||||
| 09/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.55 | General |
| Category: Immunology | ||||||
| 09/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.17 | General |
| Category: Immunology | ||||||
| 09/03/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: DERMATOLOGY | ||||||
| 08/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.07 | General |
| Category: Immunology | ||||||
| 08/27/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 08/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Immunology | ||||||
| 08/20/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: DERMATOLOGY | ||||||
| 08/16/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $7.16 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,128 | 2,196 | $296,931 | $81,993 |
| 2022 | 15 | 922 | 1,680 | $252,134 | $72,464 |
| 2021 | 14 | 709 | 1,357 | $174,500 | $55,271 |
| 2020 | 15 | 623 | 1,052 | $147,409 | $47,041 |
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 212 | 271 | $45,081 | $15,488 | 34.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 147 | 147 | $34,877 | $10,557 | 30.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 178 | 219 | $43,938 | $8,205 | 18.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 98 | 110 | $24,317 | $7,325 | 30.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 32 | 33 | $22,103 | $6,753 | 30.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 54 | 71 | $22,643 | $5,980 | 26.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 141 | 984 | $18,234 | $4,674 | 25.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $14,881 | $3,945 | 26.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 29 | 30 | $10,500 | $3,625 | 34.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 37 | 37 | $10,408 | $3,498 | 33.6% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 13 | 14 | $9,464 | $2,869 | 30.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 33 | 53 | $6,225 | $1,984 | 31.9% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 18 | 19 | $10,401 | $1,785 | 17.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 38 | 40 | $3,998 | $1,553 | 38.8% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 12 | 14 | $8,386 | $1,437 | 17.1% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 13 | 13 | $8,109 | $1,390 | 17.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 17 | 17 | $2,845 | $866.48 | 30.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 15 | 83 | $519.58 | $58.02 | 11.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 189 | 236 | $39,039 | $13,742 | 35.2% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 30 | 37 | $24,783 | $8,301 | 33.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 94 | 94 | $22,302 | $6,226 | 27.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 83 | 92 | $20,338 | $6,205 | 30.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 139 | 167 | $33,505 | $6,089 | 18.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 50 | 61 | $19,710 | $5,546 | 28.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 39 | 39 | $14,155 | $4,759 | 33.6% |
About Dr. Benjamin Vazquez, MD
Dr. Benjamin Vazquez, MD is a Dermatology healthcare provider based in Eugene, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1093918658.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Benjamin Vazquez, MD has received a total of $4,974 in payments from pharmaceutical and medical device companies, with $1,284 received in 2024. These payments were reported across 231 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($4,591).
As a Medicare-enrolled provider, Vazquez has provided services to 3,382 Medicare beneficiaries, totaling 6,285 services with total Medicare billing of $256,769. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology, Dermatology
- Location Eugene, OR
- Active Since 06/08/2007
- Last Updated 06/12/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1093918658
Products in Payments
- TREMFYA (Drug) $870.76
- TALTZ (Drug) $449.36
- REMICADE (Biological) $332.55
- Sotyktu (Drug) $260.07
- DUPIXENT (Biological) $203.45
- EUCRISA (Drug) $193.23
- SKYRIZI (Biological) $190.00
- OPZELURA (Drug) $175.90
- EPIDUO FORTE (Drug) $156.45
- COSENTYX (Drug) $139.37
- ILUMYA (Biological) $131.32
- Otezla (Drug) $129.70
- COSENTYX (Biological) $125.71
- Tremfya (Drug) $117.34
- SILIQ (Drug) $104.74
- DUPIXENT DUPILUMAB INJECTION (Biological) $96.65
- LIBTAYO (Biological) $96.18
- VTAMA (Drug) $94.54
- RINVOQ (Biological) $92.48
- Cimzia (Drug) $87.47
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Eugene
Dr. Diane Baird, M.d, M.D
Dermatology — Payments: $5,811
Troy Richey, Md Pc, MD PC
Dermatology — Payments: $3,246
Gregory Richterich, Md, MD
Dermatology — Payments: $2,626
Dr. Hannibal Eccles, Md, MD
Dermatology — Payments: $1,904
Cynthia Dreyer, M.d, M.D
Dermatology — Payments: $1,081
Dr. Chong Wee Foo, M.d, M.D
Dermatology — Payments: $793.74